Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension

NCT01365585 · clinicaltrials.gov ↗

COMPLETED

Status

227

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: sildenafil citrate

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.